Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cellsSanford P. C. Hsu, Kwan-Hwa Chi|Oncotarget|2018Cited by 43